Eliana Clark Intellia Therapeutics, Inc. (NTLA) insider trading activity

Eliana Clark is EVP, Chief Technical Officer of Intellia Therapeutics, Inc.. Currently has a direct ownership of 87,118 shares of NTLA, which is worth approximately $757,926. The most recent transaction as insider was on Jan 05, 2026, when has been sold 9,515 shares (Common Stock) at a price of $9.21 per share, resulting in proceeds of $87,633. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 87.1K

8.65% 3M change

36.02% 12M change

Total Value Held $757,926

Eliana Clark Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 05 2026	SELL Open market or private sale	$87,633 $9.21 p/Share	9,515 Reduced 9.85%	87,118 Common Stock
Jul 01 2025	SELL Open market or private sale	$10,036 $9.82 p/Share	1,022 Reduced 1.06%	95,369 Common Stock
Mar 04 2025	SELL Open market or private sale	$6,104 $8.99 p/Share	679 Reduced 0.71%	95,369 Common Stock
Mar 01 2025	BUY Grant, award, or other acquisition	-	32,000 Added 24.99%	96,048 Common Stock
Jan 03 2025	SELL Open market or private sale	$90,399 $12.18 p/Share	7,422 Reduced 10.38%	64,048 Common Stock
Jan 02 2025	SELL Open market or private sale	$6,688 $12.03 p/Share	556 Reduced 0.77%	71,470 Common Stock
Jul 01 2024	SELL Open market or private sale	$9,286 $22.93 p/Share	405 Reduced 0.56%	71,470 Common Stock

Mar 04 2024	SELL Open market or private sale	$19,958 $32.99 p/Share	605 Reduced 0.84%	71,470 Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	-	31,230 Added 30.23%	72,075 Common Stock
Jan 03 2024	SELL Open market or private sale	$137,272 $29.79 p/Share	4,608 Reduced 10.14%	40,845 Common Stock
Jul 03 2023	SELL Open market or private sale	$14,583 $40.51 p/Share	360 Reduced 0.79%	45,146 Common Stock
Jun 20 2023	SELL Open market or private sale	$225,000 $45.0 p/Share	5,000 Reduced 9.97%	45,146 Common Stock
Jun 20 2023	BUY Exercise of conversion of derivative security	$61,350 $12.27 p/Share	5,000 Added 9.07%	50,146 Common Stock
Mar 01 2023	BUY Grant, award, or other acquisition	-	30,673 Added 40.46%	45,146 Common Stock
Jan 04 2023	SELL Open market or private sale	$62,959 $37.21 p/Share	1,692 Reduced 10.47%	14,473 Common Stock
Jan 03 2023	SELL Open market or private sale	$7,964 $34.48 p/Share	231 Reduced 1.41%	16,165 Common Stock
Jul 01 2022	SELL Open market or private sale	$5,432 $51.74 p/Share	105 Reduced 0.65%	16,165 Common Stock
Mar 01 2022	BUY Grant, award, or other acquisition	-	10,527 Added 39.44%	16,165 Common Stock

Eliana Clark

EVP, Chief Technical Officer

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NTLA shares.

Notify only if

Value

Insider Trading

Get notified when an Intellia Therapeutics, Inc. insider buys or sells NTLA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Intellia Therapeutics, Inc.

Track Activities on NTLA

Account